ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Predictors of 30-day readmission in patients with bloodstream infection: a population-based cohort study.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plasma Albumin Changes During Admission for Bloodstream Infection as Prognostic Predictors After Discharge-A Population-Based Cohort Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify predictors of hospital readmissions within 30 days after discharge following a bloodstream infection (BSI).
methodsPopulation-based study of 30,843 patients surviving after their first BSI episode, 2007-2016. Using multivariate competing risk regression analyses, we estimated subhazard ratios (sHRs) and 95% confidence intervals (CIs) for all-cause, infection-related, and unplanned readmissions. Predictors included sex, age, comorbidities, causative microorganisms, length of stay (LOS), and prior hospital admissions.
resultsWithin 30 days of discharge, 9655 patients (31.3%) were readmitted of which 3333 (34.5%) were infection-related and 7725 (80.0%) unplanned. Higher risks of all-cause readmissions were observed for males (sHR [95% CI]: 1.07 [1.03-1.12]), those aged 0-15 years (1.41 [1.26-1.58]), and patients with several comorbidities, especially malignancies and liver diseases (sHR 1.26-2.09). BSIs caused by most microorganisms other than Escherichia coli also predicted an increased readmission risk (sHR 1.11-1.39). LOS in the first, third, and fourth quartiles also predicted a higher readmission risk (sHR 1.26, 1.14, and 1.25, respectively). Patients with prior hospitalization also had a higher readmission risk, within 31-365 (sHR 1.22 [1.16-1.28]) and 1-30 days (1.70 [1.61-1.79]). Results were similar for unplanned readmissions. For infection-related readmissions, only LOS in the first quartile (1-5 days) was associated with a higher readmission risk (1.67 [1.52-1.85]). Over the study period, the median LOS decreased, whereas readmission rates increased.
conclusionNearly one-third of patients discharged alive after a BSI were readmitted within 30 days. Further studies are needed to determine whether some of these readmissions may be avoidable.
Indexed as
Identifiers
41222819What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.